share_log

科濟藥業-B:翌日披露報表

CARSGEN-B: Next Day Disclosure Return

HKEX ·  Jun 19 20:12

Summary by Futu AI

科濟藥業控股有限公司(科济药业-B)於2024年6月19日提交了翌日披露報表,披露其股份變動情況。根據香港聯合交易所有限公司(香港聯交所)證券上市規則,公司已發行股份或庫存股份無變動,結存數目維持在575,653,415股。然而,公司於2024年5月31日至6月19日期間進行了多次股份回購,總計回購股份數目為2,740,000股,回購價格範圍在HKD 5.36至HKD 6.99之間。最新一次股份回購發生在2024年6月19日,當日回購700,000股,每股價格介於HKD 5.47至HKD 5.76,總支付價格為HKD 3,979,995。該公司確認,所有股份回購均按照規定進行,並無重大變動。此外,公司在股份回購後的30天內,即截至2024年7月19日,將不會進行任何新股發行或庫存股份再出售或轉讓。
科濟藥業控股有限公司(科济药业-B)於2024年6月19日提交了翌日披露報表,披露其股份變動情況。根據香港聯合交易所有限公司(香港聯交所)證券上市規則,公司已發行股份或庫存股份無變動,結存數目維持在575,653,415股。然而,公司於2024年5月31日至6月19日期間進行了多次股份回購,總計回購股份數目為2,740,000股,回購價格範圍在HKD 5.36至HKD 6.99之間。最新一次股份回購發生在2024年6月19日,當日回購700,000股,每股價格介於HKD 5.47至HKD 5.76,總支付價格為HKD 3,979,995。該公司確認,所有股份回購均按照規定進行,並無重大變動。此外,公司在股份回購後的30天內,即截至2024年7月19日,將不會進行任何新股發行或庫存股份再出售或轉讓。
On June 19, 2024, China Resources Pharmaceutical Group Limited (CR Pharma, Stock Code: 3320) submitted the next day disclosure form and disclosed its shareholding changes. According to the Listing Rules of The Hong Kong Stock Exchange Limited (HKEX), the company has not issued or repurchased any shares, and the number of shares remained at 575,653,415. However, the company conducted several share repurchases from May 31, 2024 to June 19, 2024, with a total of 2,740,000 shares repurchased at a repurchase price ranging from HKD 5.36 to HKD 6.99. The latest share repurchase occurred on June 19, 2024, with 700,000 shares repurchased at a price ranging from HKD 5.47 to HKD 5.76 and a total payment of HKD 3,979,995. The company confirms that all share repurchases are conducted in accordance with regulations and there are no significant changes. In addition, the company will not issue any new shares or sell or transfer any treasury stocks within 30 days after the share repurchase, i.e. as of July 19, 2024.
On June 19, 2024, China Resources Pharmaceutical Group Limited (CR Pharma, Stock Code: 3320) submitted the next day disclosure form and disclosed its shareholding changes. According to the Listing Rules of The Hong Kong Stock Exchange Limited (HKEX), the company has not issued or repurchased any shares, and the number of shares remained at 575,653,415. However, the company conducted several share repurchases from May 31, 2024 to June 19, 2024, with a total of 2,740,000 shares repurchased at a repurchase price ranging from HKD 5.36 to HKD 6.99. The latest share repurchase occurred on June 19, 2024, with 700,000 shares repurchased at a price ranging from HKD 5.47 to HKD 5.76 and a total payment of HKD 3,979,995. The company confirms that all share repurchases are conducted in accordance with regulations and there are no significant changes. In addition, the company will not issue any new shares or sell or transfer any treasury stocks within 30 days after the share repurchase, i.e. as of July 19, 2024.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.